SCOPUS BIOPHARMA INC (SCPS) Forecast, Price Target & Analyst Ratings

NASDAQ:SCPS • US8091711015

Current stock price

0.1682 USD
-0.17 (-50.54%)
At close:
0.12 USD
-0.05 (-28.66%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SCOPUS BIOPHARMA INC (SCPS).

Forecast Snapshot

Consensus Price Target

Price Target
$12.24
+ 7,177.05% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$12.24
Upside
+ 7,177.05%
From current price of $0.17 to mean target of $12.24, Based on 7 analyst forecasts
Low
$12.12
Median
$12.24
High
$12.60

Price Target Revisions

1 Month
0.00%
3 Months
N/A

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for SCPS. The average price target is 12.24 USD. This implies a price increase of 7177.05% is expected in the next year compared to the current price of 0.1682.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SCPS Current Analyst RatingSCPS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

SCPS Historical Analyst RatingsSCPS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
SCPS was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SCPS.
In the previous month the buy percentage consensus was at a similar level.
SCPS was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-02-16BenchmarkInitiate Speculative Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
SCPS revenue by date.SCPS revenue by date.
N/AN/AN/AN/A
EBITDA
YoY % growth
SCPS ebitda by date.SCPS ebitda by date.
N/AN/A-2.69M-10.13M
-276.58%		-19.533M
-92.82%		N/AN/AN/AN/A
EBIT
YoY % growth
SCPS ebit by date.SCPS ebit by date.
-260K-690K
-165.38%		-2.69M
-289.86%		-10.13M
-276.58%		-19.535M
-92.84%		N/AN/AN/AN/A
Operating Margin
SCPS operating margin by date.SCPS operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
SCPS eps by date.SCPS eps by date.
N/AN/AN/AN/AN/A
-55.81%		N/A
8.21%		N/A
-49.59%		N/A
22.25%		N/A
20.69%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SCPS Yearly EPS VS EstimatesSCPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-2.21%
EPS Next 5 Year
3.63%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SCOPUS BIOPHARMA INC / SCPS Forecast FAQ

Can you provide the average price target for SCOPUS BIOPHARMA INC stock?

7 analysts have analysed SCPS and the average price target is 12.24 USD. This implies a price increase of 7177.05% is expected in the next year compared to the current price of 0.1682.

Can you provide the analyst count for SCOPUS BIOPHARMA INC stock?

The number of analysts covering SCOPUS BIOPHARMA INC (SCPS) is 7.